Analyst Price Targets — NYXH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 9, 2026 10:19 am | — | Robert W. Baird | $2.85 | $1.67 | TheFly | Nyxoah price target lowered to $2.85 from $4 at Baird |
| June 17, 2026 10:54 am | — | Stifel Nicolaus | $3.00 | $1.58 | TheFly | Nyxoah price target lowered to $3 from $5 at Stifel |
| May 13, 2026 10:43 am | — | Piper Sandler | $7.00 | $3.07 | TheFly | Nyxoah price target lowered to $7 from $9 at Piper Sandler |
| May 12, 2026 1:43 am | — | Stifel Nicolaus | $5.00 | $3.33 | TheFly | Nyxoah downgraded to Hold from Buy at Stifel |
| April 10, 2026 11:43 am | Jonathan Block | Stifel Nicolaus | $8.00 | $2.90 | TheFly | Nyxoah price target lowered to $8 from $10 at Stifel |
| January 29, 2026 1:34 pm | Jonathan Block | Stifel Nicolaus | $11.00 | $4.83 | TheFly | Nyxoah price target lowered to $11 from $12 at Stifel |
| November 14, 2025 1:12 pm | Adam Maeder | Piper Sandler | $9.00 | $4.84 | StreetInsider | Nyxoah SA (NYXH) PT Lowered to $9 at Piper Sandler |
| October 14, 2024 6:45 am | Edward White | H.C. Wainwright | $17.00 | $9.60 | StreetInsider | Nyxoah SA (NYXH) PT Lowered to $17 at H.C. Wainwright |
| May 24, 2024 6:06 am | Edward White | H.C. Wainwright | $18.00 | $8.33 | TheFly | Nyxoah price target lowered to $18 from $22 at H.C. Wainwright |
| May 15, 2024 6:35 am | Ross Osborn | Cantor Fitzgerald | $17.00 | $9.58 | StreetInsider | Nyxoah SA (NYXH) PT Lowered to $17 at Cantor Fitzgerald |
Latest News for NYXH
Nyxoah NASDAQ: NYXH used its investor day presentation to outline early U.S. launch progress for its Genio hypoglossal nerve stimulation system, address reimbursement questions and describe its path toward profitability.
Nyxoah SA (NYXH) Analyst/Investor Day Transcript
Nyxoah Announces Preliminary Results for the Second Quarter of 2026 Continued U.S. launch momentum drives second quarter global preliminary net revenue of €7.7 million CMS proposes 2027 OPPS and ASC payment increase of 12% and 15% respectively Mont-Saint-Guibert, Belgium – July 7, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company…
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 30, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issuance of 146,531 new shares on June 30, 2026 following the exercise…
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), June 29, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received transparency notifications as detailed below. Orin Hirchman On June 24, 2026, Nyxoah received a…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for NYXH.
Senate Trading
No Senate trades found for NYXH.
U.S. House Trading
No House trades found for NYXH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.